ES2102772T3 - Compuesto citotoxico y antiviral. - Google Patents

Compuesto citotoxico y antiviral.

Info

Publication number
ES2102772T3
ES2102772T3 ES94300780T ES94300780T ES2102772T3 ES 2102772 T3 ES2102772 T3 ES 2102772T3 ES 94300780 T ES94300780 T ES 94300780T ES 94300780 T ES94300780 T ES 94300780T ES 2102772 T3 ES2102772 T3 ES 2102772T3
Authority
ES
Spain
Prior art keywords
cytotoxic
antiviral compound
compound
kalahide
sacoglossan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94300780T
Other languages
English (en)
Inventor
Paul J Schauer
Mark T Hamann
Dolores G Gravalos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmamar SA
Original Assignee
Pharmamar SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmamar SA filed Critical Pharmamar SA
Application granted granted Critical
Publication of ES2102772T3 publication Critical patent/ES2102772T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

KALAHIDE F DE LA FORMULA (I), PUEDE AISLARSE A PARTIR DE UN SACOGLOSAN. EL COMPUESTO PUEDE UTILIZARSE EN LA MANUFACTURA DE COMPOSICIONES FARMACEUTICAS O EN EL TRATAMIENTO DE CONDICIONES TUMORALES O VIRALES.
ES94300780T 1993-02-03 1994-02-02 Compuesto citotoxico y antiviral. Expired - Lifetime ES2102772T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939302046A GB9302046D0 (en) 1993-02-03 1993-02-03 Antiumoral compound-v

Publications (1)

Publication Number Publication Date
ES2102772T3 true ES2102772T3 (es) 1997-08-01

Family

ID=10729727

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94300780T Expired - Lifetime ES2102772T3 (es) 1993-02-03 1994-02-02 Compuesto citotoxico y antiviral.

Country Status (11)

Country Link
EP (1) EP0610078B1 (es)
JP (1) JP3452628B2 (es)
AT (1) ATE151776T1 (es)
AU (1) AU677258B2 (es)
CA (1) CA2114859C (es)
DE (1) DE69402576T2 (es)
DK (1) DK0610078T3 (es)
ES (1) ES2102772T3 (es)
GB (1) GB9302046D0 (es)
GR (1) GR3024028T3 (es)
ZA (1) ZA94748B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0002952D0 (en) * 2000-02-09 2000-03-29 Pharma Mar Sa Process for producing kahalalide F compounds
ATE314084T1 (de) 2000-10-31 2006-01-15 Pharma Mar Sa Kahalalid f formulierung
CA2462639A1 (en) * 2001-10-19 2003-04-24 Pharma Mar, S.A. Kahalalide compounds for use in cancer therapy
JP4430009B2 (ja) * 2002-10-18 2010-03-10 ファーマ・マール・エス・アー・ウー 新規な抗腫瘍化合物
GB0304367D0 (en) * 2003-02-26 2003-04-02 Pharma Mar Sau Methods for treating psoriasis
DE60335292D1 (de) * 2002-10-18 2011-01-20 Pharma Mar Sau 4-methylhexanoic kahalalide f verbindung
US7507708B2 (en) 2003-02-26 2009-03-24 Pharma Mar, S.A.U. Antitumoral compounds
GB0321066D0 (en) 2003-09-09 2003-10-08 Pharma Mar Sau New antitumoral compounds
KR20100099128A (ko) * 2007-10-19 2010-09-10 파르마 마르 에스.에이. 개선된 항암치료
US20110015135A1 (en) * 2008-03-07 2011-01-20 Pharma Mar S.A. Antitumoral Treatments
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE83480T1 (de) * 1988-09-05 1993-01-15 Sankyo Co Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
US4986988A (en) * 1989-05-18 1991-01-22 Arizona Board Of Regents Isolation and structural elucidation of the cytostatic linear depsipeptides dolastatin 13 and dehydrodolastatin 13

Also Published As

Publication number Publication date
CA2114859C (en) 2008-04-15
DE69402576D1 (de) 1997-05-22
AU5491194A (en) 1994-08-11
JP3452628B2 (ja) 2003-09-29
ATE151776T1 (de) 1997-05-15
GR3024028T3 (en) 1997-10-31
CA2114859A1 (en) 1994-08-04
GB9302046D0 (en) 1993-03-24
EP0610078B1 (en) 1997-04-16
AU677258B2 (en) 1997-04-17
DK0610078T3 (da) 1997-10-20
EP0610078A1 (en) 1994-08-10
DE69402576T2 (de) 1997-10-02
ZA94748B (en) 1994-09-29
JPH0770185A (ja) 1995-03-14

Similar Documents

Publication Publication Date Title
DE69426904T2 (de) Phosphonat-Nukleotid Ester-Derivate
FI905983A (fi) Aminosyraderivat.
HUT59109A (en) Process for producing hydroxymethyl-(methylenecyclopentyl)-purines and -pyrimidines, their pharmaceutically acceptable salts and pharmaceutical compositions comprising same
ATE269290T1 (de) Benzoylderivate
NO943002D0 (no) Fosfono-oksymetyletere av taxanderivater
TW226375B (es)
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
IL94484A0 (en) Diarylstyrylquinoline diacids and pharmaceutical compositions containing them
DK0509398T3 (da) Quinoxaliner, fremgangsmåder til deres fremstilling samt deres anvendelse
DK0604183T3 (da) HIV-protease-inhibitorer anvendelige i behandlingen af AIDS
ES2102772T3 (es) Compuesto citotoxico y antiviral.
KR910700089A (ko) 히드로클로로플루오로프로판의 공비 조성물 또는 공비형 조성물
FI960658A0 (fi) Uudet bis-naftalimidit syövän hoitamiseksi
ATE237619T1 (de) Sesquiterpen-derivate mit antiviraler aktivität
EP0551844A3 (es)
EP0412941A3 (en) Phospholipids for the treatment of multiple sclerosis
IT1230053B (it) Composizione per l'aumento del guadagno di peso.
IT8821384A0 (it) 5 pirimidincarbossamidi sostituite e composizioni farmaceutiche contenenti le stesse per il trattamento di leucemia.
IT1262952B (it) Tetraalchilpiperidine, loro preparazione e loro impiego come stabilizzanti alla luce. (caso 153-5502)

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 610078

Country of ref document: ES